Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 1,621 $ (53,396)
Adjustments to reconcile net loss to net cash flows from operating activities    
Depreciation and amortization 45 54
Impairment loss on long-term investment   524
Inventory reserve 596  
Amortization of discount of notes payable and convertible notes payable 3,200 21,875
Foreign exchange adjustments on convertible notes and notes payable (316) (207)
Net (gain) loss on investment in marketable securities (7,672) 21,718
Loss on equity method investment 1,474 413
Loss on debt extinguishment 1,425 438
Share-based compensation and fair value of replacement equity award 549 3,593
Notes conversion costs   3,341
Change in fair value of warrant derivative liabilities (669) (3,492)
Change in fair value of embedded conversion option (51) (131)
Net changes in operating assets and liabilities    
Accounts receivable 425 (193)
Inventories (44) (2,787)
Prepaid expenses and other current assets 336 (1,025)
Other non-current assets 313 (4,150)
Income tax receivable and payable (43) (82)
Accounts payable and accrued expenses (3,119) 5,966
Deferred revenue   500
Deferred rent   (287)
Other current liabilities (3,883) 828
Other long-term liabilities 1,451 2,363
Net cash flows used in operating activities (4,362) (4,137)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid in connection with the Merger   (1,641)
Sale of marketable securities 35,601 221
Purchases of property and equipment (13) (55)
Loan made to equity investee (2,274)  
Net cash flows provided by (used in) investing activities 33,314 (1,475)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from notes payable issued, net of issuance cost and discount 1,980  
Payments of notes payable (200)  
Payments of convertible notes (2,000) (3,368)
Proceeds from exercise of warrants   186
Proceeds from issuance of common stock 142 6,210
Net cash flows provided by (used in) financing activities (78) 3,028
Effect of exchange rate changes on cash (14) 5
Net increase (decrease) in cash, cash equivalents and restricted cash 28,860 (2,579)
Cash, cash equivalents and restricted cash, beginning of period 1,769 3,905
Cash, cash equivalents and restricted cash, end of period 30,629 1,326
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES    
Interest paid 1,543 1,239
Income taxes paid 126 242
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Warrants issued $ 3,808  
Beneficial conversion feature relating to convertible notes   8,764
Warrant liabilities reclassified to equity   6,337
Conversion of notes payable to common stock   33,777
Conversion of accrued interest payable to common stock   2,381
Initial recognition of right to use assets   $ 2,922